(MedPage Today) — Children with infantile-onset Pompe’s disease experienced motor function and cardiac improvements after receiving an adeno-associated virus serotype 9 (AAV9)-mediated gene therapy, a pilot study showed.
Among four pediatric…
Source link : https://www.medpagetoday.com/neurology/generalneurology/116250
Author :
Publish date : 2025-06-25 21:00:00
Copyright for syndicated content belongs to the linked Source.
